![Christina A. Waters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christina A. Waters held several positions in the biopharmaceutical industry, including Director of Scientific Development at Novartis Institute for Functional Genomics, Manager of Preclinical Studies Program at Miravant Medical Technologies, President of CTI Sede Secondaria at CTI BioPharma Corp., President and COO at aTyr Pharma, Associate at Howard Hughes Medical Institute, and President at Systems Medicine, Inc. She also served as Chief Development and Marketing Officer at The Multiple Myeloma Research Foundation.
Waters earned an undergraduate degree from San Diego State University, a doctorate from the University of California, Davis, and an MBA from the University of California, Los Angeles.
| Unternehmen | Position | Ende |
|---|---|---|
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | - |
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Vertrieb & Marketing | - |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Technik-/Wissenschafts-/F&E-Leiter | - |
Systems Medicine, Inc.
 Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Develops oncology products by integrating predictive cellular pharmacogenomics | Präsident | - |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 10 |
|---|---|
Miravant Medical Technologies
 Miravant Medical Technologies Pharmaceuticals: MajorHealth Technology Develops light activated drugs and associated devices for photodynamic therapy | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Commercial Services |
Systems Medicine, Inc.
Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Develops oncology products by integrating predictive cellular pharmacogenomics | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
